Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
37 hedge funds and large institutions have $15.9M invested in Psychemedics Corporation in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 17 reducing their positions, and 7 closing their positions.
12% less funds holding
Funds holding: 42 → 37 (-5)
35% less capital invested
Capital invested by funds: $24.4M → $15.9M (-$8.52M)
47% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 17
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$875K |
| 2 |
2L
22NW LP
Seattle,
Washington
|
+$231K |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$210K |
| 4 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
+$91.7K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$47.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tieton Capital Management
Yakima,
Washington
|
-$766K |
| 2 |
Renaissance Technologies
New York
|
-$266K |
| 3 |
CIS
Connors Investor Services
Wyomissing,
Pennsylvania
|
-$196K |
| 4 |
LBA
Lowell Blake & Associates
Boston,
Massachusetts
|
-$112K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$93.1K |
PMD Hedge Fund Activity: Q1 2020 in Review
37 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q1 2020, worth a combined $15.9M — down 35% from $24.4M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of PMD and 2 opened new positions — a net loss of 5 holders — while 17 trimmed existing stakes and 9 added.
The largest buyer was Kennedy Capital Management, adding an estimated $875K. The largest seller was Tieton Capital Management, cutting an estimated $766K.
- 37 institutional investors held Psychemedics Corporation (PMD) as of Q1 2020, down from 42 in Q4 2019.
- Funds reported $15.9M of Psychemedics Corporation stock for Q1 2020, down 35% quarter-over-quarter.
- 2 funds opened new Psychemedics Corporation positions in Q1 2020 and 7 closed out, a net change of -5 holders.
- The largest Psychemedics Corporation buyer in Q1 2020 was Kennedy Capital Management, an estimated $875K added.
- The largest Psychemedics Corporation seller in Q1 2020 was Tieton Capital Management, an estimated $766K sold.
Based on aggregated 13F filings for Q1 2020.